Is Ceres Ventures, Inc. (CEVE) a Buy, Sell, or Hold?
OTC : CEVE
Ceres Ventures, Inc.
$0.0001 USD
$0 (0.0%)
- Volume
- 115
- Average Volume
- 21
- Market Capitalization
- $8.55K
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.21
Company Overview
OTC
Frank J. Fabio
Medical - Care Facilities
Healthcare
CEVE
0
US
USD
Liquidity Metrics
-0.28
0.21
0.21
0.21
0.00
Sales & Valuation
-$
0.00
-0.02
-0.03
0.00
Profitability
-$0.01
-$572K
0.00%
0.00%
225.93%
-346.69%
P/E Metrics
-0.01
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-52.24
1/9
-$337.06K
$80480.0
$485.94K
-$744.25K
Key Metrics (TTM)
$6613.0
0.00
-0.01
0.21
225.93%
203.10%
-8354.51%
-3035.82%
0 days
Company Executives
| Name | Title |
|---|---|
| Frank J. Fabio | Interim Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Ceres Ventures, Inc. (OTC:CEVE) Stock
Ceres Ventures, Inc. is an emerging clean technology firm dedicated to developing and bringing to market innovative environmental solutions aimed at purifying contaminated water, soil, and air. The company's core technological offerings comprise: BluFlow Nanoparticles: A proprietary system that engineers and deploys tailor-made absorbent nanoparticles. These microscopic particles are designed to precisely capture and remove various contaminants and chemicals, and can also be utilized to recover valuable elements and compounds from aquatic environments. BluFlow Advanced Ultrafiltration Technology: An automated ultrafiltration process focused on reclaiming clean water from industrial waste streams and other impure liquid sources. The BluFlow Treatment System, which integrates both the Nanopa ... rticle and Advanced Ultrafiltration technologies. This comprehensive solution effectively eliminates a broad spectrum of pollutants, compounds, and undesirable elements, rendering water sufficiently pure for potential reuse. These solutions find diverse applications, including municipal and industrial water and wastewater purification, remediation of tainted groundwater, and the extraction of valuable resources from various solutions. Previously operating as PhytoMedical Technologies, Inc., the company adopted its current name, Ceres Ventures, Inc., in November 2011. Its headquarters are located in New York, New York.
Frequently Asked Questions
-
What is the current Ceres Ventures, Inc. (CEVE) stock price?
-
Ceres Ventures, Inc.(OTC:CEVE) stock price is $0.0001 in the last trading session. During the trading session, CEVE stock reached the peak price of $0.0002 while $0.0001 was the lowest point it dropped to. The percentage change in CEVE stock occurred in the recent session was 0.0% while the dollar amount for the price change in CEVE stock was $0.
-
CEVE's industry and sector of operation?
-
The OTC listed CEVE is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
-
Who are the executives of CEVE?
-
Frank J. Fabio | Interim Chief Financial Officer
|
|
|
| -
How many employees does CEVE have?
-
Number of CEVE employees currently stands at 0. CEVE operates from 430 Park Avenue, New York City, NY 10022, US.
-
Link for CEVE official website?
-
Official Website of CEVE is: http://ceres.ventures
-
How do I contact CEVE?
-
CEVE could be contacted at phone #800-611-3388 and can also be accessed through its website. CEVE operates from 430 Park Avenue, New York City, NY 10022, US.
-
How many shares of CEVE are traded daily?
-
The average number of CEVE shares traded daily for last 3 months was 21.
-
What is the market cap of CEVE currently?
-
The market value of CEVE currently stands at $8.55K with its latest stock price at $0.0001